These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 11419069)

  • 1. [Mifepristone--a new antiprogesterone in obstetrics and gynecology].
    Aschkenazi S; Levy T; Ben-Rafael Z
    Harefuah; 2001 May; 140(5):429-34. PubMed ID: 11419069
    [No Abstract]   [Full Text] [Related]  

  • 2. [Present and potential uses of mifepristone in gynecology, obstetrics and other medical specialties].
    Weingertner AS; Hamid D; Baldauf JJ; Nisand I
    J Gynecol Obstet Biol Reprod (Paris); 2004 Dec; 33(8):692-702. PubMed ID: 15687940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical applications of the antiprogestins.
    Kettel LM
    Clin Obstet Gynecol; 1995 Dec; 38(4):921-34. PubMed ID: 8616987
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clinical application of mifepristone in obstetrics and gynecology].
    Weng L
    Zhonghua Fu Chan Ke Za Zhi; 1999 May; 34(5):261-4. PubMed ID: 11326928
    [No Abstract]   [Full Text] [Related]  

  • 5. [Multiple usages for antiprogestins].
    Heikinheimo O
    Duodecim; 1994; 110(10):1001-8. PubMed ID: 7588093
    [No Abstract]   [Full Text] [Related]  

  • 6. RU486 (mifepristone): mechanisms of action and clinical uses.
    Cadepond F; Ulmann A; Baulieu EE
    Annu Rev Med; 1997; 48():129-56. PubMed ID: 9046951
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mifepristone: a potential clinical agent based on its anti-progesterone and anti-glucocorticoid properties.
    Sun Y; Fang M; Davies H; Hu Z
    Gynecol Endocrinol; 2014 Mar; 30(3):169-73. PubMed ID: 24205903
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [National symposium on clinical application of mifepristone in obstetrics and gynecology].
    Jiang M; Weng L; Wu Y; Wu S
    Zhonghua Fu Chan Ke Za Zhi; 1999 May; 34(5):265-7. PubMed ID: 11326929
    [No Abstract]   [Full Text] [Related]  

  • 9. Approval of mifepristone (RU 486) in Europe.
    Sitruk-Ware R
    Zentralbl Gynakol; 2000; 122(5):241-7. PubMed ID: 10857210
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of antigestagens on human reproduction].
    Zalányi S; Kovács L
    Orv Hetil; 2001 Apr; 142(16):827-31. PubMed ID: 11340944
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Mifepristone (RU-486), from hell to purgatory].
    Botella Llusiá J
    An R Acad Nac Med (Madr); 1999; 116(1):21-34; discussion 34-8. PubMed ID: 10554390
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mifepristone (RU 486): current knowledge and future prospects.
    Goldberg JR; Plescia MG; Anastasio GD
    Arch Fam Med; 1998; 7(3):219-22. PubMed ID: 9596454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Antiprogestin to clinical use].
    Heikinheimo O
    Duodecim; 2000; 116(12):1261-2. PubMed ID: 11988960
    [No Abstract]   [Full Text] [Related]  

  • 14. [Early termination of pregnancy with pharmacological means].
    Honkanen H; von Hertzen H
    Duodecim; 2000; 116(12):1277-82; quiz 1283, 1308. PubMed ID: 11988962
    [No Abstract]   [Full Text] [Related]  

  • 15. Mifepristone: contraceptive and non-contraceptive uses.
    Ho PC; Yu Ng EH; Tang OS
    Curr Opin Obstet Gynecol; 2002 Jun; 14(3):325-30. PubMed ID: 12032390
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical applications of mifepristone.
    Tang OS; Ho PC
    Gynecol Endocrinol; 2006 Dec; 22(12):655-9. PubMed ID: 17162706
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Tumor necrosis factor and induced labor].
    Rongières-Bertrand C; Menu E; Lelaidier C; Delage G; Chaouat G; Frydman R
    Contracept Fertil Sex; 1997 Jan; 25(1):51-7. PubMed ID: 9064053
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Mifepristone--a controversial drug with great potential].
    Bjørge L; Iversen OE
    Tidsskr Nor Laegeforen; 2001 Nov; 121(28):3286-91. PubMed ID: 11826459
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Embryo Survival after Mifepristone: A Systematic Review of the Literature.
    Davenport M; Delgado G; Harrison MP; Khauv V
    Issues Law Med; 2017; 32(1):3-18. PubMed ID: 29108160
    [No Abstract]   [Full Text] [Related]  

  • 20. Comment: analysis of severe adverse events related to the use of mifepristone as an abortifacient.
    Shannon CS
    Ann Pharmacother; 2006 Jun; 40(6):1215-6; author reply 1216-7. PubMed ID: 16735658
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.